Intelligence · Patents
Patents expiring in 2037
Annual patent cliff calendar for 2037 — US pharmaceutical patents by expiration date.
- Patents
- 1,615
Quick answer
1,615 indexed pharmaceutical patents have expiration dates in 2037. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 9708615
Therapeutic compositions
granted -
US 9707215
Inhibitors of hepatitis C virus polymerase
granted -
US 9707206
Mast cell stabilizers treatment for systemic disorders
granted -
US 9707252
Synthetic sealants
granted -
US 9707270
Method for administering ω-conopeptide
granted -
US 9713459
Method and system for in vivo hydrogen peroxide detection with ultrasound
granted -
US 9714421
Compositions and methods
granted -
US 9714226
Hydrazide containing nuclear transport modulators and uses thereof
granted -
US 9714270
a4B7 integrin thioether peptide antagonists
granted -
US 9714246
[9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido-[2,1-a]isoquinolin-2-yl]methanol and compounds, compositions and methods relating thereto
granted -
US 9714241
Cyclopropanamine compound and use thereof
granted -
US 9714232
Substituted piperazine compounds and methods of use thereof
granted -
US 9713611
Abuse resistant pharmaceutical compositions
granted -
US 9713637
Bacillus anthracis HtrA-defective-derived vaccines
granted -
US 9713628
Transplantation of neural cells
granted -
US 9713638
Compositions and methods for rapid immunization against dengue virus
granted -
US 9713635
Materials and methods for producing improved lentiviral vector particles
granted -
US 9713607
Salinosporamides and methods of use thereof
granted -
US 9713600
Method for treating metabolic syndrome
granted -
US 9713595
Sustained-release composition and method for producing the same
granted -
US 9713599
Parenteral formulations of treprostinil
granted -
US 9714288
Antisense compounds and uses thereof
granted -
US 9714244
Substituted pyrido[4,3-d]pyrimidines as Wee-1 inhibitors
granted -
US 9713612
Compounds for treatment of cancer
granted -
US 9713585
Nail coatings having enhanced adhesion
granted -
EP 3193911
VERBESSERTE FAKTOR-VIII-PRÄPARATIONEN FÜR THERAPEUTISCHE VERWENDUNG UND VERFAHREN ZUR ERHALTUNG DERSELBEN
granted -
US 9717752
Uses of antagonists of hyaluronan signaling
granted -
US 9719103
Increasing levels of nicotinic alkaloids in plants
granted -
US 9718851
Deuterated nucleoside/tide derivatives
granted -
US 9718811
(S)-enantiomer of mepazine
granted -
US 9719144
Microbiome markers and therapies for autism spectrum disorders
granted -
US 9719088
Micro-RNA family that modulates fibrosis and uses thereof
granted -
US 9719087
Micro-RNA family that modulates fibrosis and uses thereof
granted -
US 9717759
Modification of CXCR4 using engineered zinc finger proteins
granted -
US 9718921
Amphiphilic derivatives of thioether containing block copolypeptides
granted -
US 9717797
Polycarbonates bearing aromatic N-heterocycles for drug delivery
granted -
US 9717742
Oxysterol analogue OXY133 induces osteogenesis and hedgehog signaling and inhibits adipogenesis
granted -
US 9718778
Mixed disulfide conjugates of thienopyridine compounds and uses thereof
granted -
US 9719089
Nucleic acid functionalized nonoparticles for therapeutic applications
granted -
US 9717716
Methods of sedation during critical care treatment
granted -
US 9717710
Treatment of mild and moderate Alzheimer's disease
granted -
US 9717679
Methods for the prevention and treatment of animal skin conditions
granted -
US 9718881
Anti-Activin A antibodies and uses thereof
granted -
US 9717672
Compositions and methods for UV-curable cosmetic nail coatings
granted -
US 9717660
Fluoride releasing dental composition and dental appliance
granted -
US 9718835
20(S)-sulfonylamidine derivatives of camptothecin and the use thereof as a potent antitumor agent
granted -
US 9719080
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)
granted -
US 9718841
Bicyclic pyrazolone compounds and methods of use
granted
Frequently asked questions
How many pharma patents expire in 2037?
1,615 published patents in our USPTO index have expiration dates falling in calendar year 2037.